13338 Federal Register / Vol. 66, No. 43 / Monday, March 5, 2001 / Notices

[FR Doc. 01–5175 Filed 3–2–01; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be listed at the end, and will be omitted

from the monthly listing thereafter.

This Notice is also available on the

internet at the following website:http://

www.health.org/workplace.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, 5600

Fishers Lane, Rockwall 2 Building,

Room 815, Rockville, Maryland 20857;

Tel.: (301) 443–6014, Fax: (301) 443–

3031.

Special Note: Please use the above address

for all surface mail and correspondence. For

all overnight mail service use the following

address: Division of Workplace Programs,

5515 Security Lane, Room 815, Rockville,

Maryland 20852.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratories, 8901 W. Lincoln

Ave., West Allis, WI 53227, 414–328–

7840/800–877–7016(Formerly:

Bayshore Clinical Laboratory)

Advanced Toxicology Network, 3560

Air Center Cove, Suite 101, Memphis,

TN 38118, 901–794–5770/888–290–

1150

Aegis Analytical Laboratories, Inc., 345

Hill Ave., Nashville, TN 37210, 615–

255–2400

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/334–263–5745

Alliance Laboratory Services, 3200

Burnet Ave., Cincinnati, OH 45229,

513–585–9000 (Formerly: Jewish

Hospital of Cincinnati, Inc.)

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

20151, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866/800–433–2750

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783

(Formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Clinical Laboratory Partners, LLC, 129

East Cedar St., Newington, CT 06111,

860–696–8115 (Formerly: Hartford

Hospital Toxicology Laboratory)

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–269–3093 (Formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, Building

38–H, P.O. Box 88–6819, Great Lakes,

IL 60088–6819, 847–688–2045/847–

688–4171

Diagnostic Services Inc., dba DSI, 12700

Westlinks Drive, Fort Myers, FL

33913, 941–561–8200/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31602,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

206–386–2672/800–898–0180

(Formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

Dynacare Kasper Medical Laboratories,*

14940–123 Ave., Edmonton, Alberta,

Canada T5V 1B4, 780–451–3702/800–

661–9876

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 662–236–

2609

Express Analytical Labs, 1301 18th Ave

NW, Suite 110, Austin, MN 55912,

507–437–7322

Gamma-Dynacare Medical

Laboratories,* A Division of the

Gamma-Dynacare Laboratory

Partnership, 245 Pall Mall St.,

London, ONT, Canada N6A 1P4, 519–

679–1630

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Integrated Regional Laboratories, 5361

NW 33rd Avenue, Fort Lauderdale, FL

33309, 954–777–0018, 800–522–0232,

(Formerly: Cedars Medical Center,

Department of Pathology)

Kroll Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–

361–8989/800–433–3823, (Formerly:

Laboratory Specialists, Inc.)

LabOne, Inc., 10101 Renner Blvd.,

Lenexa, KS 66219, 913–888–3927/

800–728–4064, (Formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America

Holdings, 7207 N. Gessner Road,

Houston, TX 77040, 713–856–8288/

800–800–2387

Laboratory Corporation of America

Holdings, 1904 Alexander Drive,

Research Triangle Park, NC 27709,

919–572–6900/800–833–3984,

(Formerly: LabCorp Occupational

Testing Services, Inc., CompuChem

Laboratories, Inc.; CompuChem

Laboratories, Inc., A Subsidiary of

Roche Biomedical Laboratory; Roche

CompuChem Laboratories, Inc., A

Member of the Roche Group)

Laboratory Corporation of America

Holdings, 4022 Willow Lake Blvd.,

Memphis, TN 38118, 866–827–8042/

Federal Register / Vol. 66, No. 43 / Monday, March 5, 2001 / Notices 13339

800–233–6339, (Formerly: LabCorp

Occupational Testing Services, Inc.,

MedExpress/National Laboratory

Center)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 908–526–2400/800–437–4986

(Formerly: Roche Biomedical

Laboratories, Inc.)

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–331–3734

MAXXAM Analytics Inc.,* 5540

McAdam Rd., Mississauga, ON,

Canada L4Z 1P1, 905–890–2555,

(Formerly: NOVAMANN (Ontario)

Inc.)

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43699, 419–383–5213

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

651–636–7466/800–832–3244

MetroLab-Legacy Laboratory Services,

1225 NE 2nd Ave., Portland, OR

97232, 503–413–5295/800–950–5295

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 661–322–4250/800–350–3515

Northwest Drug Testing, a division of

NWT Inc., 1141 E. 3900 South, Salt

Lake City, UT 84124, 801–293–2300/

800–322–3361, (Formerly: NWT Drug

Testing, NorthWest Toxicology, Inc.)

One Source Toxicology Laboratory, Inc.,

1705 Center Street, Deer Park, TX

77536, 713–920–2559 (Formerly:

University of Texas Medical Branch,

Clinical Chemistry Division; UTMB

Pathology-Toxicology Laboratory)

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–687–2134

Pacific Toxicology Laboratories, 6160

Variel Ave., Woodland Hills, CA

91367, 818–598–3110/800–328–6942,

(Formerly: Centinela Hospital Airport

Toxicology Laboratory

Pathology Associates Medical

Laboratories, 11604 E. Indiana Ave.,

Spokane, WA 99206, 509–926–2400/

800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

650–328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–215–8800 (Formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–339–0372/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 858–279–

2600/800–882–7272

Quest Diagnostics Incorporated, 3175

Presidential Dr., Atlanta, GA 30340,

770–452–1590 (Formerly: SmithKline

Beecham Clinical Laboratories,

SmithKline Bio-Science Laboratories)

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 248–373–9120/800–444–0106,

(Formerly: HealthCare/Preferred

Laboratories, HealthCare/MetPath,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated, 8000

Sovereign Row, Dallas, TX 75247,

214–638–1301 (Formerly: SmithKline

Beecham Clinical Laboratories,

SmithKline Bio-Science Laboratories)

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 972–

916–3376/800–526–0947 (Formerly:

Damon Clinical Laboratories, Damon/

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 801

East Dixie Ave., Suite 105A, Leesburg,

FL 34748, 352–787–9006x4343

(Formerly: SmithKline Beecham

Clinical Laboratories, Doctors &

Physicians Laboratory)

Quest Diagnostics Incorporated, 400

Egypt Rd., Norristown, PA 19403,

610–631–4600/800–877–7484

(Formerly: SmithKline Beecham

Clinical Laboratories, SmithKline BioScience Laboratories)

Quest Diagnostics Incorporated, 506 E.

State Pkwy., Schaumburg, IL 60173,

800–669–6995/847–885–2010

(Formerly: SmithKline Beecham

Clinical Laboratories, International

Toxicology Laboratories)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 619–686–3200/800–446–

4728 (Formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590 (Formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated, 7600

Tyrone Ave., Van Nuys, CA 91405,

818–989–2520/800–877–2520

(Formerly: SmithKline Beecham

Clinical Laboratories)

San Diego Reference Laboratory, 6122

Nancy Ridge Dr., San Diego, CA

92121, 800–677–7995/858–677–7970

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

S.E.D. Medical Laboratories, 5601 Office

Blvd., Albuquerque, NM 87109, 505–

727–6300/800–999–5227

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Tempe, AZ 85283, 602–

438–8507/800–279–0027

Sparrow Health System, Toxicology

Testing Center, St. Lawrence Campus,

1210 W. Saginaw, Lansing, MI 48915,

517–377–0520, (Formerly: St.

Lawrence Hospital & Healthcare

System)

St. Anthony Hospital Toxicology

Laboratory, 1000 N. Lee St.,

Oklahoma City, OK 73101, 405–272–

7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 818–996–7300/800–339–

4299 (Formerly: MetWest-BPL

Toxicology Laboratory)

Universal Toxicology Laboratories, LLC,

9930 W. Highway 80, Midland, TX

79706, 915–561–8851/888–953–8851

* The Standards Council of Canada (SCC)

voted to end its Laboratory Accreditation

Program for Substance Abuse (LAPSA)

effective May 12, 1998. Laboratories certified

through that program were accredited to

conduct forensic urine drug testing as

required by U.S. Department of

Transportation (DOT) regulations. As of that

date, the certification of those accredited

Canadian laboratories will continue under

DOT authority. The responsibility for

conducting quarterly performance testing

plus periodic on-site inspections of those

LAPSA-accredited laboratories was

transferred to the U.S. DHHS, with the

DHHS’ National Laboratory Certification

Program (NLCP) contractor continuing to

have an active role in the performance testing

and laboratory inspection processes. Other

Canadian laboratories wishing to be

considered for the NLCP may apply directly

to the NLCP contractor just as U.S.

laboratories do. Upon finding a Canadian

laboratory to be qualified, the DHHS will

recommend that DOT certify the laboratory

(Federal Register, 16 July 1996) as meeting

the minimum standards of the ‘‘Mandatory

Guidelines for Workplace Drug Testing’’ (59

Federal Register, 9 June 1994, Pages 29908–

29931). After receiving the DOT certification,

the laboratory will be included in the

monthly list of DHHS certified laboratories

13340 Federal Register / Vol. 66, No. 43 / Monday, March 5, 2001 / Notices

and participate in the NLCP certification

maintenance program.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 01–5230 Filed 3–2–01; 8:45 am]

BILLING CODE 4160–20–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration (SAMHSA)

Notice of Meetings

Pursuant to Public Law 92–463,

notice is hereby given of the following

meetings of SAMHSA Special Emphasis

Panels I in March, April and May.

A summary of the meetings and a

roster of the members may be obtained

from: Ms. Coral Sweeney, Review

Specialist, SAMHSA, Office of Policy

and Program Coordination, Division of

Extramural Activities, Policy, and

Review, 5600 Fishers Lane, Room 17–

89, Rockville, Maryland 20857.

Telephone: 301–443–2998.

Substantive program information may

be obtained from the individual named

as Contact for the meeting listed below.

The meetings will include the review,

discussion and evaluation of individual

grant applications. These discussions

could reveal personal information

concerning individuals associated with

the applications. Accordingly, these

meetings are concerned with matters

exempt from mandatory disclosure in

Title 5 U.S.C. 552b(c) (6) and 5 U.S.C.

App.2, § 10(d).

Committee Name: SAMHSA Special

Emphasis Panel I (SEP I).

Meeting Date: March 2001.

Place: SAMHSA / DEAPR, Parklawn

Building, 5600 Fishers Lane, Room 17089,

Rockville, Maryland 20817,

Closed: Entire Meeting.

Panel: Conference Grants PA 98–90.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Committee Name: SAMHSA Special

Emphasis Panel I (SEP I),

Meeting Date: March 2001.

Place: SAMHSA, DEAPR, Parklawn

Building, 5600 Fishers Lane, Room 17089,

Rockville, Maryland 20817.

Closed: Entire Meeting.

Panel: Community Action Grants, CSAT,

Room 1789, Rockville, Maryland 20857.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Committee Name: SAMHSA Special

Emphasis Panel I (SEP I).

Meeting Date: April 2001.

Place: Four Points by Sheraton, 8400

Wisconsin Avenue, Bethesda, Maryland

20814.

Closed: Entire Meeting.

Panel: Community Initiated Prevention

Intervention, SP 00–01.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Committee Name: SAMHSA Special

Emphasis Panel (SEP I).

Meeting Date: April 2001.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, Maryland 20814.

Closed: Entire Meeting.

Panel: Targeted Capacity Expansion, PA

00–01.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Committee Name: SAMHSA Special

Emphasis Panel I (SEP I).

Meeting Date: April/May 2001.

Place: Four Points by Sheraton, 8400

Wisconsin Avenue, Bethesda, Maryland

20814.

Closed: Entire Meeting.

Panel: Community Comprehensive

Treatment Program, PA 99–080.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Committee Name: SAMHSA Special

Emphasis Panel (SEP I).

Meeting Date: May 2001.

Place: SAMHSA, DEAPR, Parklawn

Building, 5600 Fishers Lane, Room 17089,

Rockville, Maryland 20817.

Closed: Entire Meeting.

Panel: State Incentive Grant, Homeless II.

Contact: Diane McMenamin, Director,

Division of Extramural Activities, Policy and

Review.

Dated: February 13, 2001.

Coral Sweeney,

Review Specialist, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 01–5159 Filed 3–2–01; 8:45 am]

BILLING CODE 4162–20–P

DEPARTMENT OF THE INTERIOR

Office of the Secretary

Exxon Valdez Oil Spill Public Advisory

Group Meeting

AGENCY: Department of the Interior,

Office of the Secretary.

ACTION: Notice of meeting.

SUMMARY: The Department of the

Interior, Office of the Secretary is

announcing a public meeting of the

Exxon Valdez Oil Spill Public Advisory

Group.

DATES: April 4, 2001, at 9 a.m.

ADDRESSES: Fourth floor conference

room, 645 ‘‘G’’ Street, Anchorage,

Alaska.

FOR FURTHER INFORMATION CONTACT:

Douglas Mutter, Department of the

Interior, Office of Environmental Policy

and Compliance, 1689 ‘‘C’’ Street, Suite

119, Anchorage, Alaska, (907) 271–

5011.

SUPPLEMENTARY INFORMATION: The

Public Advisory Group was created by

Paragraph V.A.4 of the Memorandum of

Agreement and Consent Decree entered

into by the United States of America

and the State of Alaska on August 27,

1991, and approved by the United States

District Court for the District of Alaska

in settlement of United States of

America v. State of Alaska, Civil Action

No. A91–081 CV. The meeting agenda

will feature an orientation for Public

Advisory Group members and briefings

on the Gulf Ecosystem Monitoring

program and the annual restoration

work plan.

Dated: February 27, 2001.

Willie R. Taylor,

Director, Office of Environmental Policy and

Compliance.

[FR Doc. 01–5257 Filed 3–2–01; 8:45 am]

BILLING CODE 4310–RG–P

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

Endangered and Threatened Species

Permit Application

AGENCY: Fish and Wildlife Service,

Interior.

ACTION: Notice of receipt of application.

The following applicants have

applied for permits to conduct certain

activities with endangered species. This

notice is provided pursuant to section

10(c) of the Endangered Species Act of

1973, as amended (16 U.S.C. 1531, et

seq.).

Permit Number TE038823

Applicant: Christopher W. Sanders,

Sayre, Pennsylvania

The applicant requests a permit to

take (capture, handle and release) the

Indiana bat (Myotis sodalis), Virginia

big-eared bat (Corynorhinus townsendii

virginianus), and gray bat (Myotis

grisescens). Activities are proposed for

studies throughout the range of the

Indiana bat (Eastern and Midwestern

U.S.) to identify populations

(mistnetting, harp trapping,

echolocation), develop methods to

minimize or avoid project related

impacts to those populations (radio

telemetry, banding), and to identify new

populations of Indiana bats. The

scientific research is aimed at

enhancement of survival of the species

in the wild.